Hide Board Information

Show Board Information

PharmaCyte Biotech Inc. PMCB

Board Mod: Add me as mod

Asst Mods:

Last Post: 11/15/2023 8:10:49 AM

Board Marks: 56

Posts Today: 0

Board Views Today: 7

PharmaCyte Biotech Inc. (NASDAQ: PMCB) Stock Message Board

1. PMCB Company Profile

    

2. PMCB Time & Sales

    

3. PMCB Recent News

    

4. PMCB Filings

    

5. PMCB Financials

    

6. PMCB Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

350	NVLX news:	stocklegend	02/05/2014 9:16:53 AM
349	$NVLX Nuvilex Begins Making Moves at its	stocklegend	02/05/2014 9:14:54 AM
348	$NVLX Nuvilex's Medical Marijuana Subsidiary	stocklegend	02/05/2014 8:36:19 AM
347	$NVLX Nuvilex COO, Dr. Gerald Crabtree,	stocklegend	02/04/2014 3:13:24 PM
346	$NVLX Nuvilex COO Talks About Companys	stocklegend	02/04/2014 2:57:56 PM
345	$NVLX Nuvilex, Inc. Featured on Forbes:	stocklegend	02/04/2014 2:01:40 PM
344	$NVLX Nuvilex Listed in Forbes Article on	stocklegend	02/04/2014 12:57:25 PM
343	$NVLX - Nuvilex COO Talks Medical Marijuana in NY	stocklegend	02/04/2014 12:20:16 PM
342	$NVLX - Nuvilex Featured in Forbes and NY Post	stocklegend	02/04/2014 11:52:46 AM
341	$NVLX - Nuvilex Acquires Cancer Cell	stocklegend	02/04/2014 11:13:02 AM
340	$NVLX - Nuvilex Acquires Cancer Technology, Next	stocklegend	02/04/2014 10:47:16 AM
339	$NVLX - Nuvilex Restructures its Operations to	stocklegend	02/04/2014 10:03:55 AM
338	$NVLX - Nuvilex Restructures to Focus on	stocklegend	02/04/2014 9:27:09 AM
337	$NVLX - Nuvilex Contracts with Inno Biologics to	stocklegend	02/04/2014 9:08:30 AM
336	$NVLX - Nuvilex Enters Most Important Step of	stocklegend	02/04/2014 8:54:06 AM
335	$NVLX Nuvilex Announces Cloning of Cells for	stocklegend	02/03/2014 3:41:01 PM
334	$NVLX Nuvilex Completes Acquisition of	stocklegend	02/03/2014 3:27:37 PM
333	$NVLX Nuvilex Accelerates Development of	stocklegend	02/03/2014 3:17:08 PM
332	$NVLX Nuvilex's Acquisition of Diabetes	stocklegend	02/03/2014 2:03:06 PM
331	$NVLX Nuvilex Ahead of the Curve on	stocklegend	02/03/2014 1:51:15 PM
330	$NVLX Investors Confidently Back Nuvilex's	stocklegend	02/03/2014 1:08:20 PM
329	$NVLX After Pancreatic Cancer, Eli Lilly and	stocklegend	02/03/2014 11:45:26 AM
328	$NVLX Nuvilex and Eli Lilly Going Head to	stocklegend	02/03/2014 11:27:11 AM
327	$NVLX Nuvilex Appoints Dr. Mark Rabe, a	stocklegend	02/03/2014 10:15:30 AM
326	$NVLX Nuvilex Begins Making Moves at its	stocklegend	02/03/2014 9:06:03 AM
325	$NVLX Nuvilex's Medical Marijuana Subsidiary	stocklegend	02/03/2014 8:37:39 AM
324	$NVLX Nuvilex COO, Dr. Gerald Crabtree,	stocklegend	01/31/2014 3:07:13 PM
323	$NVLX Inno Biologics Begins Cell Cloning	stocklegend	01/31/2014 2:54:11 PM
322	$NVLX Nuvilex Announces Cloning of Cells for	stocklegend	01/31/2014 2:14:26 PM
321	$NVLX Nuvilex Completes Acquisition of	stocklegend	01/31/2014 1:37:36 PM
320	$NVLX Nuvilex Accelerates Development of	stocklegend	01/31/2014 12:52:18 PM
319	$NVLX Nuvilex's Acquisition of Diabetes	stocklegend	01/31/2014 12:47:29 PM
318	$NVLX Nuvilex Ahead of the Curve on	stocklegend	01/31/2014 12:35:42 PM
317	$NVLX Investors Confidently Back Nuvilex's	stocklegend	01/31/2014 11:33:16 AM
316	$NVLX Diabetes Treatment Drives Big Increase	stocklegend	01/31/2014 10:55:18 AM
315	$NVLX After Pancreatic Cancer, Eli Lilly and	stocklegend	01/31/2014 10:15:24 AM
314	$NVLX Nuvilex and Eli Lilly Going Head to	stocklegend	01/31/2014 9:47:55 AM
313	$NVLX Nuvilex Appoints Dr. Mark Rabe, a	stocklegend	01/31/2014 9:38:08 AM
312	$NVLX Nuvilex Begins Making Moves at its	stocklegend	01/31/2014 9:02:53 AM
311	$NVLX Nuvilex's Medical Marijuana Subsidiary	stocklegend	01/31/2014 8:48:16 AM
310	$NVLX Nuvilex Ahead of the Curve on	stocklegend	01/30/2014 3:46:34 PM
309	$NVLX Investors Confidently Back Nuvilex's	stocklegend	01/30/2014 3:22:19 PM
308	$NVLX Diabetes Treatment Drives Big Increase	stocklegend	01/30/2014 3:01:59 PM
307	$NVLX After Pancreatic Cancer, Eli Lilly and	stocklegend	01/30/2014 2:29:34 PM
306	$NVLX Nuvilex and Eli Lilly Going Head to	stocklegend	01/30/2014 1:52:13 PM
305	$NVLX Nuvilex Appoints Dr. Mark Rabe, a	stocklegend	01/30/2014 1:16:44 PM
304	$NVLX Nuvilex Begins Making Moves at its	stocklegend	01/30/2014 12:34:49 PM
303	$NVLX Nuvilex's Medical Marijuana Subsidiary	stocklegend	01/30/2014 12:16:25 PM
302	$NVLX - Nuvilex Featured in Forbes and NY Post	stocklegend	01/30/2014 11:19:33 AM
301	$NVLX - Nuvilex Acquires Cancer Cell	stocklegend	01/30/2014 10:57:48 AM

Newer

Older

Recent Articles

• Aroundtown SA's 9M 2024 Financial Performance and Outlook
• Navigating Euro's Volatility: Insights for Global Investors
• Investors Seek Protection Amid Record U.S. Stock Market Rally
• Taiwan Stock Market Experiences Notable Declines and Gains
• Hesai Group Sees Major Shift in Lidar Tech for Electric Cars
• Hydro's 2030 Vision: Leading the Charge in Green Aluminium
• Huawei's Mate 70 Series Challenges Apple's Premium Smartphone Domination
• Asian Markets React Cautiously to Tariff Threats
• New Zealand Economy Surprises with Stronger Growth Estimates
• OpenAI's Strategic Share Sale to SoftBank: A New Era in AI
• ASX 200 Gains Boosted by Webjet's Significant Rise
• OpenAI Enables Employee Stock Sales Worth $1.5 Billion
• Analyst Predicts Massive Growth Potential for POL Cryptocurrency
• JD Vance's Strategic Investments in ETFs and Bitcoin Explained
• Market Insights: Rising Gold Prices Amid Trade Tariff Concerns
• Explore the Best AI Stocks to Invest in for Growth
• Revitalizing Cultural Heritage: Jiaozhou's Remarkable Journey
• Lottery.com Inc. Takes Steps Towards Compliance with NASDAQ
• Turkey Adjusts $23 Billion F-16 Fighter Jet Procurement Plans
• Bengbu Hosts 4th International New Materials Conference
• UBS Predicts Federal Reserve's Rate Cut Plans for 2025
• Boeing 737 MAX Safety Update: No Immediate Action Required
• BYD Implements Price Reduction Strategy for Suppliers' Benefit
• Potential Shift in Crypto Regulation Under New Administration
• Asian Markets React to Tariff Threats and Economic Data
• Revolutionizing Defense: How Tech Can Transform Warfare
• Cathie Wood's Bold Vision: $400B in Biologics Awakening
• Market Reactions to Tariff Threats: An Asian Perspective
• Foxconn Strengthens Global Manufacturing Amid Tariff Concerns
• Leaked OpenAI Sora Model Sparks Artist Allegations and Concerns
• Cryptocurrency Market Shifts as Investors Take Profits
• JOYY Inc. Delivers Impressive Q3 Financial Results and Buybacks
• Vietnam Aims for U.S. Market Economy Recognition and Growth
• Citi Analysts Warn Increase in Tariffs May Affect S&P 500
• Hyundai Motor Announces Major Share Buyback Plan Worth $716M
• Cathie Wood’s Strategic Shift: Ark Invest Cuts Tesla Holdings
• Oil Prices Dip as Traders Assess Geopolitical Developments
• EngageSmart Investors Alert: Key Dates for Class Action Suit
• Disney Settles $43M Gender Pay Discrimination Lawsuit
• Securities Fraud Class Action Filed Against Dentsply Sirona Inc.
• Oil Prices Maintain Stability Amid Ceasefire Discussions and OPEC+ Meeting
• China's Industrial Profit Decline Signals Economic Challenges
• Sri Lanka Implements New Monetary Policy for Economic Recovery
• KKR's Interest Spurs Rise in Seven & i Holdings Shares
• Key Insights on Amazon, CrowdStrike, Autodesk, Dell, and Tesla Stocks
• BrilliA Inc Sets its Initial Public Offering Price at $4.00
• Important Update for Match Group Shareholders on Legal Action
• Brazil Potash Sets Price for Initial Public Offering of Shares
• Securities Fraud Class Action Launched Against Rentokil Initial
• RBNZ Implements Significant Rate Cut to Stimulate Recovery